壹生资讯-『Day9』终于开始治疗了！并不复杂，然而……

您已通过HCP身份认证和信息审核

(

『Day9』终于开始治疗了！并不复杂，然而……

2020-08-11作者：论坛报心血管活动

高血压病例

前情回顾：

『Day1』这例高血压为何难治？如果诊治前有一段“冷静期”……
『Day2』看了这个病人的资料，陈源源教授想……
『Day3』这例高血压为何难治？查体结果透露了什么？
『Day4』看了病人的体检结果，陈源源教授想……
『Day5』做了一堆辅助检查，真的都查全了吗？
『Day6』看了病人的辅助检查结果，陈源源教授认为……
『Day7』对于这个诊断，你满意吗？
『Day8』对于这个诊断，陈源源教授说……

治疗

患者住院后结合症状、体征及相关辅助检查，调整药物方案为：

给予钙拮抗剂硝苯地平控释片、α/β受体阻滞剂卡维地洛、硝酸酯类药物硝酸异山梨酯控释片联合控制血压；

阿司匹林联合华法林抗凝、抗栓，定期监测华法林的安全性；

同时加强对患者的宣教。

对于这个治疗方案，你怎么看？请投票作出你的思考和选择：

（明日公布陈源源教授对查体结果的分析，敬请期待！）

{"attendFlag":0,"createTime":1596106639000,"dayEndTime":"23:45","dayStartTime":"00:00","endTime":1597248000000,"hideVotenum":false,"id":110097396,"isBindWx":0,"isOpenValidate":0,"items":[{"createTime":1596106638000,"filepathIds":"","id":2456,"imagePattern":0,"images":[],"isMultiple":0,"isNecessary":0,"maxChoicesNum":1,"minChoicesNum":1,"options":[{"createTime":1596106639000,"description":"","filepathIds":"","id":10027,"images":[],"isRight":0,"researchId":110097396,"researchItemId":2456,"title":"是（请在评论中补充原因）","userCount":1,"userId":161},{"createTime":1596106639000,"description":"","filepathIds":"","id":10028,"images":[],"isRight":0,"researchId":110097396,"researchItemId":2456,"title":"否（请在评论中补充原因）","userCount":6,"userId":161}],"researchId":110097396,"title":"Q1：患者多处动脉狭窄，是否应再次介入治疗？","userCount":7,"userId":161},{"createTime":1596106638000,"filepathIds":"","id":2457,"imagePattern":0,"images":[],"isMultiple":0,"isNecessary":0,"maxChoicesNum":1,"minChoicesNum":1,"options":[{"createTime":1596106639000,"description":"","filepathIds":"","id":10029,"images":[],"isRight":0,"researchId":110097396,"researchItemId":2457,"title":"140/90 mmHg以下（请在评论中补充原因）","userCount":3,"userId":161},{"createTime":1596106639000,"description":"","filepathIds":"","id":10030,"images":[],"isRight":0,"researchId":110097396,"researchItemId":2457,"title":"130/80 mmHg以下（请在评论中补充原因）","userCount":4,"userId":161}],"researchId":110097396,"title":"Q2：患者的降压目标是？","userCount":7,"userId":161},{"createTime":1596106638000,"filepathIds":"","id":2458,"imagePattern":0,"images":[],"isMultiple":0,"isNecessary":0,"maxChoicesNum":1,"minChoicesNum":1,"options":[{"createTime":1596106639000,"description":"","filepathIds":"","id":10031,"images":[],"isRight":0,"researchId":110097396,"researchItemId":2458,"title":"合适（请在评论中补充原因）","userCount":6,"userId":161},{"createTime":1596106639000,"description":"","filepathIds":"","id":10032,"images":[],"isRight":0,"researchId":110097396,"researchItemId":2458,"title":"不合适（请在评论中补充原因）","userCount":1,"userId":161}],"researchId":110097396,"title":"Q3：肾动脉轻中度狭窄时RAS抑制剂为特异性选择，本例没有使用，你认为是否合适？原因是？","userCount":7,"userId":161},{"createTime":1596106638000,"filepathIds":"","id":2459,"imagePattern":0,"images":[],"isMultiple":0,"isNecessary":0,"maxChoicesNum":1,"minChoicesNum":1,"options":[{"createTime":1596106639000,"description":"","filepathIds":"","id":10033,"images":[],"isRight":0,"researchId":110097396,"researchItemId":2459,"title":"维持现有方案（请在评论中补充原因）","userCount":1,"userId":161},{"createTime":1596106639000,"description":"","filepathIds":"","id":10034,"images":[],"isRight":0,"researchId":110097396,"researchItemId":2459,"title":"应改用新型抗凝药（请在评论中补充原因）","userCount":6,"userId":161}],"researchId":110097396,"title":"Q4：对于抗凝方案，你的观点？","userCount":7,"userId":161}],"itemsMap":{2456:{"isMultiple":0,"rightOptions":[]},2457:{"isMultiple":0,"rightOptions":[]},2458:{"isMultiple":0,"rightOptions":[]},2459:{"isMultiple":0,"rightOptions":[]}},"joinRange":0,"mark":2,"modifyTime":1596106638000,"researchType":0,"startTime":1597075200000,"title":"终于开始治疗了！并不复杂，然而……","userId":161,"voteCount":1}

200 评论

知情同意书

『Day9』终于开始治疗了！并不复杂，然而……

热门资讯

关于我们

中国医学论坛报微信矩阵

助力乡村振兴帮扶行动

友情链接